» Articles » PMID: 38353109

Rs895819 TC Genotype Increases Risk of Fluoropyrimidine-induced Severe Toxicity Independently of Variations

Overview
Specialties Genetics
Pharmacology
Date 2024 Feb 14
PMID 38353109
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNA 27a (miR-27a) regulates post-transcriptionally DPD activity. We have analyzed the association of rs895819T>C variation, that modulates miR-27a expression, with fluropyrimidine-induced toxicity. rs895819T>C genotyping was conducted by TaqMan® allelic discrimination assay in 313 FP-treated cancer patients. In overdominance (TC vs TT + CC), TC genotype was associated with grade 3-4 toxicity (p = 0.002), any grade toxicity (p = 0.052), and delayed drug administration or therapy discontinuation (p = 0.038). Odds of grade 3-4 toxicity were increased by both deficiency (OR: 8.923; p = 0.006) and rs895819 TC genotype (OR: 3.865; p = 0.002). rs895819 TC genotype is an independent risk factor for fluoropyrimidine-associated toxicity in the Greek population. Thus, rs895819TC patients can be closely monitored for fluoropyrimidine-induced severe toxicity.

Citing Articles

MIR27A rs895819 CC Genotype Severely Reduces miR-27a Plasma Expression Levels.

Ragia G, Pallikarou M, Michou C, Manolopoulos V Genes (Basel). 2024; 15(11).

PMID: 39596691 PMC: 11593693. DOI: 10.3390/genes15111491.


Gene Polymorphism Modifies the Effect of Common Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy.

Ikonnikova A, Fedorinov D, Gryadunov D, Heydarov R, Lyadova M, Moskalenko A Int J Mol Sci. 2024; 25(15).

PMID: 39126072 PMC: 11313059. DOI: 10.3390/ijms25158503.